The US finally declared the jobs data on Friday. The results, however, led to a decline in the major indices of the Indian stock market for the third consecutive session. The SENSEX closed 1.24% low at 81,183.93, while the NIFTY fell below the 25000 mark and closed red at 24,852.15. Despite the fall in most sectors and stocks, some company shares stayed positive and made it to the list of top performers of the day.
As the market opens at 9:00 AM today, we present 20 stocks to consider adding to your watchlist. Here are ten stocks with the highest trading volume and ten stocks based on their performance at yesterday’s market close.
Top 10 performers from NIFTY 500 today
| Sno | Symbol | CMP | Performance |
| 1 | GODFRYPHLP | 7115.00 | 10.96 % |
| 2 | FLUOROCHEM | 3,785.10 | 7.40 % |
| 3 | GLS | 1,148.00 | 5.03 % |
| 4 | USHAMART | 354.35 | 4.21 % |
| 5 | SUMICHEM | 538.30 | 4.13 % |
| 6 | SBICARD | 799.40 | 4.13 % |
| 7 | NH | 1348.00 | 3.89 % |
| 8 | SUVENPHAR | 1,195.15 | 3.83 % |
| 9 | GMMPFAUDLR | 1,412.00 | 3.66 % |
| 10 | MARICO | 666.90 | 3.57 % |
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. Past performance is not indicative of future results.
Understanding the Top 5 Performing Stocks Today
Godfrey Phillips India Ltd.:
Godfrey Phillips India, part of the KK Modi Group, is a major player in India’s FMCG space. It holds 14% of the domestic cigarette market with brands like Four Square, Red & White, and Cavanders. The company also has an exclusive agreement with Philip Morris International to produce and distribute Marlboro in India. Apart from cigarettes, it offers a strong confectionery line, including the Funda brand, for global markets. Over three years, its stock rose 633.01%, outperforming Nifty FMCG’s 57.27% and NIFTY 50’s 43.01% as of 6th September 2024. As of FY2024, the company’s net profit reached Rs.880.84 crore from FY2023’s profit of Rs.608.83 crore, giving an earning per equity share of Rs.196.41. [Source Godfrey Phillips}
Gujarat Fluorochemicals Limited:
Gujarat Fluorochemicals Limited, part of the INOX Group, was formed in 2018 after its demerger from GFL Ltd. It is a top producer of fluoro-polymers, fluoro-specialties, chemicals, and refrigerants in India. Globally, it’s among the top five players in the fluoropolymers market, exporting to Europe, the Americas, Japan, and Asia. Some of its well-known brands include Inoflon, Flounox, Inoflar, Inoclub, and Refron. With a presence in 16 countries, the company has seen a 20% CAGR over the past five years. Backed by 30 years of expertise in fluorine chemistry, it achieved Rs.4,281 crores in revenue for FY2024, with Rs.435 crores in PAT and a 10% PAT margin. Its ROCE for FY2024 is 14.63%.
Glenmark Life Sciences Limited:
Glenmark Life Sciences Limited is a leading name in developing and manufacturing Active Pharmaceutical Ingredients (APIs). It prioritizes research and innovation, continuously enhancing its product lineup with an R&D infusion of Rs.75.3 crore (as of FY2024). With 142 APIs, it supplies over 700 pharmaceutical companies globally. As of FY2024, the company’s revenue from operations grew by 5.6% to Rs.2283.2 crore, and its profit (after tax) was Rs.470.9 crore with a PAT margin of 20.6%. On 6th September 2024, the stock’s PE ratio was 29.97, compared to the sectoral PE of 49.75. Additionally, the company’s 3-year revenue CAGR stood at 6.8%.
Usha Martin Limited:
Usha Martin Ltd, founded in 1960, specializes in manufacturing and selling steel wires, wire ropes, strands, and related machines. Over time, it has grown into a market leader with a multi-unit, multi-product portfolio. Its Ranchi facility is one of the largest wire rope factories globally. Usha Martin operates in 70+ countries through 250+ distribution centers and partners. In FY2024, the company formed a new entity in Saudi Arabia to serve the oil, energy, and infrastructure sectors and acquired complete control of a joint venture in Thailand. As of FY2024, the company’s revenue was ₹3,225.2 crore (down 1.3%), while PAT rose 21% to ₹424.1 crore, with a ROCE of 21.9%.
Sumitomo Chemical India Ltd.:
Sumitomo Chemical India Ltd. (SCIL) is a key player in agrochemicals, animal nutrition, and environmental health, backed by its Japanese parent, Sumitomo Chemical Company. SCIL has a balanced portfolio of technical and formulation products, with backward integration for some. The integration of Excel Crop Care strengthened its generics and specialty products portfolio, boosting its position in India’s crop protection market. SCIL also has a global presence, including in Africa. In FY2024, SCIL acquired a majority stake in Barrix Agro Sciences, specializing in pheromones. SCIL’s revenue for FY2024 stood at ₹2,843.9 crore, with a PAT of ₹369.7 crore and an ROCE of 20.8%.
Top 10 volume gainers stocks from NIFTY 500 today
| Sno | Symbol | Volume | Volume Change % |
| 1 | INDIGOPNTS | 24461452 | 11684.40 % |
| 2 | FLUOROCHEM | 2838149 | 640.85 % |
| 3 | SAPPHIRE | 3767279 | 621.80 % |
| 4 | GMDCLTD | 4035278 | 559.94 % |
| 5 | SBICARD | 16337930 | 455.19 % |
| 6 | ASTRAZEN | 67592 | 438.03 % |
| 7 | AAVAS | 1577478 | 400.57 % |
| 8 | GLS | 1405761 | 395.12 % |
| 9 | SUMICHEM | 2276631 | 376.51 % |
| 10 | SUVENPHAR | 1405226 | 310.59 % |
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. Past performance is not indicative of future results.
Understanding the stocks of the list:
Indigo Paints Ltd.:
Indigo Paints started in 2000, focusing on decorative paints like emulsions, putties, primers, and wood coatings, all under the ‘Indigo’ brand. Based in Pune, it has plants in Jodhpur, Kochi, and Pudukkottai. In FY24, Indigo Paints acquired Apple Chemie India, expanding into construction and waterproofing products. This acquisition boosted Apple Chemie’s growth by 50% in the fourth quarter of FY2024. Indigo Paints reported a revenue of Rs.1,320.3 crore for FY2024, a 21.87% increase from FY2023, with a net profit of Rs.147.32 crore, achieving an 11.27% profit margin. However, the one-year stock growth of the company share was -6.91% as of 6th September 2024. [Source Indigo Paints Ltd]
Sapphire Foods India Limited:
Sapphire Foods India Limited is one of India’s largest QSR companies, backed by Sapphire Foods Mauritius Limited and private equity investors. With a long-term ownership structure, it holds a 25.1% equity lock-in with YUM. Sapphire Foods operates over 400 KFC, Pizza Hut, and Taco Bell outlets across India, Sri Lanka, and the Maldives. In FY2024, its revenue grew by 15%, reaching Rs.2588 crore. As of the June 2024 quarter, the company reported a net profit of Rs.8.19 crore. Plus, over the past five years, it has maintained a 26% CAGR in profit growth.
Gujarat Mineral Development Corporation Ltd.:
Gujarat Mineral Development Corporation Ltd. (GMDC) is a top player in India’s mining and power sectors. We focus on lithium, bauxite, Fluorspar, multi-metal, manganese, and renewable energy like wind and solar. With zero debt, GMDC ranks 469th in India’s Fortune 500 (2023) and is among the top five mining companies by market cap. We’re India’s second-largest Lignite producer and the leader in Gujarat, supplying to industries like textiles, chemicals, ceramics, and power. In FY2024, GMDC achieved its third-highest turnover of Rs.2463 crore and a net profit of Rs.614 crore, maintaining a 34.9% dividend payout.
SBI Cards & Payment Services Ltd:
SBI Card, launched in 1998 by the State Bank of India and GE Capital, made history in March 2020 as the first credit card company to list on Indian stock exchanges. Registered with the RBI, it’s a non-deposit-accepting nonbanking financial company based in Gurgaon, Haryana, and a subsidiary of India’s largest bank. As of FY204, SBI Card has 1.89 crore cards in force, leading the market with an 18.6% share. For FY 2023-24, it’s the second-largest credit card issuer in India by spending and card numbers. The company achieved revenue of ₹17,484 crore, reflecting a 22% YoY growth and a PAT of ₹2,408 crore, up 7% YoY.
Indigo Paints Limited:
AstraZeneca Pharma India Ltd makes and markets pharmaceutical products. It’s backed by AstraZeneca plc from England and has a broad range of medicines, including the Oxford-AstraZeneca COVID-19 vaccine. AstraZeneca Pharmaceuticals AB owns 75% of its shares. In the June 2024 quarter, the company reported a loss of ₹11.79 crore after three profitable quarters. However, its annual revenue grew by 29.27%, beating its 3-year CAGR of 17.01%. Over the past three years, its stock rose by 115.53%, outperforming the Nifty Midcap 100’s 103.8% return as of 6th September 2024.
Recent weakness in the US markets has slowed down momentum in Indian markets. Investors are now cautious as they await more data on upcoming jobs. At the same time, Nifty has dropped below the key 20-day exponential moving average (DEMA), suggesting more declines could be on the horizon. It is thus suggested that you carefully consider the market trends before concluding any investment decision.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This article is for education purposes only and shall not be considered as a recommendation or investment advice by Equentis – Research & Ranking. We will not be liable for any losses that may occur. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL & the certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
I’m Archana R. Chettiar, an experienced content creator with
an affinity for writing on personal finance and other financial content. I
love to write on equity investing, retirement, managing money, and more.
